The spoligotyping-based population structure of multidrug-resistant (MDR) Mycobacterium tuberculosis strains isolated in Poland (n ‫؍‬ 46), representing all culture-positive MDR tuberculosis (MDR-TB) cases, was compared to that of isoniazid (INH)-monoresistant strains (n ‫؍‬ 71) isolated in 2004. The latter data set from a previous study (E. Augustynowicz-Kopeć, T. Jagielski, and Z. Zwolska, J. Clin. Microbiol. 2008, 46:4041-4044) represented 87% of all INH-monoresistant strains. The clustering rates and genotypic-diversity indexes for the 2 subpopulations were not significantly different (P ‫؍‬ 0.05). The results were entered in the SITVIT2 database to assign specific shared type designations, corresponding genotypic lineages, and geographical distributions and compared to available data from neighboring countries (Germany, n ‫؍‬ 704; Czech Republic, n ‫؍‬ 530; Sweden, n ‫؍‬ 379; Kaliningrad, Russia, n ‫؍‬ 90) and strains from previous studies in Poland (n ‫؍‬ 317). MDR strains resulted in 27 patterns (20 unique strains within the study and 7 clusters containing 2 to 6 isolates per cluster with a clustering rate of 56.5%) and belonged to the following genotypic lineages: ill-defined T family (28.3%), Haarlem (17.4%), Latin American and Mediterranean (LAM) (13%), Beijing (8.7%), S family (4.35%), and the X clade (2.17%). Comparison of the genetic structure of the MDR strains with that of INH-monoresistant strains showed that a total of 9 patterns were shared by both groups; these represented 1/3 of the MDR strains and 2/3 of the INH-monoresistant strains. Interestingly, 76.1% of the MDR isolates and 71.8% of the INH-resistant isolates yielded spoligotypes that were previously reported from Poland. The observation that nearly half of the spoligotypes identified among both MDR (48.1%) and INH-monoresistant (43.3%) M. tuberculosis isolates were present in Poland's neighboring countries suggested that a significant proportion of MDR and INH-resistant TB cases in Poland were caused by strains actively circulating in Poland or its neighbors. Our results corroborate the leading role of the T and Haarlem genotypes in the epidemiology of drug-resistant TB in Poland. Nevertheless, the LAM and Beijing family strains that infected, correspondingly, 13% and 9% of patients with MDR-TB were absent among the strains from patients with INHmonoresistant TB, suggesting that a proportion of MDR-TB cases in Poland are due to ongoing transmission of MDR clones exhibiting specific genotypes. Study of the population genetic relationships between MDR and INH-monoresistant strains by drawing minimum spanning trees showed that ill-defined T1 sublineage strains (1/3 of all INH-monoresistant strains), represented by its prototype, SIT53, constituted the central node of the tree, followed by strains belonging to the well-defined H3, H1, and S subgroups. However, the MDR group, in addition, contained LAM (n ‫؍‬ 6) and Beijing (n ‫؍‬ 4) lineage isolates. With the exception of the 4 Beijing lineage strains in the latter group and a single orphan isolate in the INH-monoresistant group, none of the remaining 112/117 isolates belonged to principal genetic group 1 (PGG1) in our study. Given the high rate of clustering and the near absence of immigrants in the study, the persistence of MDR-TB in Poland seems to result from active transmission of MDR strains within the autochthonous population, the bulk of it caused by evolutionarily recent tubercle bacilli.
Tuberculosis (TB) remains a substantial global health problem. With more than 9 million new cases and almost 2 million deaths every year (50) , TB holds one of the leading positions among infectious causes of morbidity and mortality worldwide. One of the reasons for the continuing TB prevalence is the emergence and spread of drug-resistant (DR) and, especially, multidrug-resistant (MDR) (i.e., resistant to at least isoniazid [INH] and rifampin [RMP] ) Mycobacterium tuberculosis strains. According to a recent World Health Organization (WHO) report, the global population weighted percentages for any resistance and MDR among all TB cases are 20% and 5.3%, respectively (49) . Poland, the largest and most populous country in Central Europe (38, 530 ,000 inhabitants in 2002), has witnessed a dramatic fall in the incidence of TB over the last few decades. While in 1957 the notification rate for all clinical forms was 290.4 per 100,000 population, it had dropped almost 10-fold by the end of 1990s (43) . However, the TB notification rate in Poland is still relatively high, nearly twice the mean European Union (EU) rate (24.6/100,000 versus 12.8/100,000 in 2004) (14) .
Since the early years of chemotherapy for TB, the prevalence of primary drug-resistant TB in Poland has been closely monitored. In 1994, Poland joined the WHO/International Union against Tuberculosis and Lung Disease (IUATLD) global project on anti-TB drug resistance surveillance, and during 1996 and 1997, the first national survey on primary and acquired drug resistance was performed. The subsequent study, completed in 2001, revealed a 2-fold increase in the primary resistance rate in comparison with that in 1997, i.e., 6.1% versus 3.6%, respectively. Likewise, the prevalence of primary multidrug resistance doubled, from 0.6% in 1997 to 1.2% in 2000 (3) . In 2004, there was a slight decrease to 5.6% in the percentage of TB cases with primary drug resistance and quite a significant fall to 0.3% in the share of multidrug-resistant tuberculosis (MDR-TB) cases compared to 2000 (49) . These figures place Poland among the countries with low to moderate DR-TB rates in the world. However, inadequacies in the registration of TB patients may contribute to an underestimation of drug-resistant cases. The most detrimental impact on the epidemiology of TB in Poland might be the spread of DR-TB from outside the country. This is because Poland shares borders with countries of the former Soviet Union, such as Lithuania, Ukraine, and Russia, where the incidence of DR-TB, including MDR-TB, is exceptionally high (49) . Given the geographical epidemiological context, the surveillance capacity for TB in Poland has to be particularly well established.
Studying genetic relationships among M. tuberculosis strains has provided important insights into the spread and transmission of TB (8, 15, 26, 30, 31, 34) . Spoligotyping targeting the polymorphism of the chromosomal direct-repeat locus is one of the most extensively used techniques for genotypic differentiation between M. tuberculosis strains (27) . Primarily used for first-line screening of outbreaks (22, 40) , spoligotyping is ideally followed by more discriminatory second-line IS6110 restriction fragment length polymorphism (RFLP) or mycobacterial interspersed repetitive-unit-variable-number tandem-repeat (MIRU-VNTR) typing (9, 24) . It has also proven useful for tracking laboratory cross-contaminations (36) and describing the global spread of TB (9, 17) . Major advantages of the spoligotyping technique are its simplicity, rapidity, reproducibility, and portability, due to the digital nature of the generated results. Of particular importance is the existence of the international spoligotype database, which provides useful information on the epidemiology and phylogeny of the circulating genotypes of tubercle bacilli worldwide (9) .
This study aimed to investigate the spoligotyping-based population structure of MDR M. tuberculosis clinical isolates isolated in Poland in 2004 compared to that of INH-monoresistant strains isolated in the same year. Indeed, as reviewed by Dye and Espinal (12) , a high proportion of TB patients carrying INH-monoresistant strains acquire RMP resistance after treatment failure, suggesting that the development of INH resistance usually precedes that to RMP.
MATERIALS AND METHODS
Patients and specimens. This study included a total of 46 MDR strains of M. tuberculosis isolated from as many TB patients in Poland. The patients (40 men and 6 women; age range, 31 to 79 years; median age, 50.5 years) were recruited in several TB clinics across Poland during a 1-year period from 1 January 2004 to 31 December 2004 (Fig. 1) . Primary isolation, species identification, and drug susceptibility testing (DST) were done at regional mycobacteriology laboratories. The isolates were subcultured and sent to the National TB Reference Laboratory (NTRL) at the National Tuberculosis and Lung Diseases Research Institute in Warsaw, where confirmatory identification and DST were performed. Testing of susceptibility to the first-line drugs was carried out according to the 1% proportion method in Löwenstein-Jensen medium, with the following critical concentrations: streptomycin (SM), 4 g/ml; INH, 0.2 g/ml; RMP, 40 g/ml; and ethambutol (EMB), 2 g/ml. Basic demographic data were collected for each patient, using a standard questionnaire prepared by the NTRL, and sent to the local TB laboratories.
Spoligotyping and database comparison. DNAs extracted by the cetyltrimethylammonium bromide (CTAB) method (47) were stored at Ϫ20°C before being subjected to spoligotyping using a previously described protocol (27) . Briefly, the direct-repeat region of the TB genome was amplified using primers DRa and DRb, and the amplified biotinylated products were hybridized to a set of 43 oligonucleotides covalently bound to a membrane (Isogen Life Science B.V., Utrecht, Netherlands). The hybridized PCR products were incubated with streptavidin-peroxidase conjugate, and signal detection was obtained with an enhanced chemiluminescence detection system (Amersham, Little Chalfont, England), followed by exposure to X-ray film (Hyperfilm ECL; Amersham) according to the manufacturer's instructions. The X-ray film was developed using standard photochemical procedures after overnight exposure. Spoligotypes in binary format were converted to an octal code for comparison with the SITVIT2 proprietary database of the Pasteur Institute of Guadeloupe, which is an updated version of the previously released SpolDB4 database (9; available online at http://www.pasteur-guadeloupe.fr:8081/SITVITDemo). At the time of the present study, SITVIT2 contained genotyping information on 70,000 M. tuberculosis clinical isolates from 160 countries of origin. In the database, SIT (spoligotype international type) designates a spoligotype shared by 2 or more patient isolates, as opposed to "orphan," which designates patterns reported for a single isolate. Major phylogenetic clades were assigned according to signatures provided in SpolDB4, which defined 62 genetic lineages/sublineages (9). They include specific signatures for various M. tuberculosis complex species, as well as major lineages/sublineages for M. tuberculosis sensu stricto, e.g., Central Asian (CAS), East African-Indian (EAI), Haarlem (H), Latin American-Mediterranean (LAM), Manu, S clade, the IS6110 low-banding X clade, and an ill-defined T clade.
Phylogenetic and statistical analyses. Correlation of spoligotype families and principal genetic groups (PGG) based on KatG463-gyrA95 polymorphisms was inferred from the reported linking of specific spoligotype patterns to PGG1 (ancient lineages) and PGG2/3 (modern lineages) (9, 42) . The evolutionary relationships among the spoligotype patterns obtained were further studied by drawing a minimum spanning tree (MST) with Bionumerics software (version 3.5; Applied Maths, Sint-Martens-Latem, Belgium). The MSTs were drawn for the INH-monoresistant (n ϭ 71) and MDR (n ϭ 46) populations independently, as well as a combined tree for all the isolates taken together (n ϭ 117). An MST is an undirected network in which all the samples are linked together with the smallest possible linkages between nearest neighbors.
The chi-square test or Fisher's exact test (if the cell count was less than 5) was performed to evaluate differences in demographic and epidemiologic characteristics between MDR-TB and INH-monoresistant-TB patients. Differences between the genotypic-diversity indexes were assessed by the two-proportion test. A P value that was less than 0.05 was considered statistically significant.
RESULTS AND DISCUSSION
This study included all bacteriologically confirmed MDR-TB cases in Poland over a 1-year period (2004; n ϭ 46 isolates from as many TB patients). These MDR-TB cases represented 18.7% of all drug-resistant-TB cases reported in Poland throughout 2004 (smear-positive TB cases registered [total] , n ϭ 9,493; any drug resistance, n ϭ 246; INH-monoresistant isolates, n ϭ 82; MDR-TB isolates, n ϭ 46). The results obtained by spoligotyping of the MDR-TB isolates compared to the INH-monoresistant isolates (n ϭ 71) are summarized in Tables 1 and 2 . Whenever available, a phylogenetic clade description for each SIT was also provided, as well as their geographical distribution among neighboring countries, limited to Germany (n ϭ 704), Czech Republic (n ϭ 530), Sweden (n ϭ 379), and Kaliningrad, Russia (n ϭ 90), as well as Poland (strains from previous studies; n ϭ 317). For the 46 clinical isolates, spoligotyping produced a total of 27 different patterns (genetic diversity, 58.7%), 4 of which corresponded to orphan patterns (not found among more than 70,000 strains recorded in the SITVIT2 database). The remaining 42 (91.3%) strains from this study belonged to 23 SITs, including the 3 newly created SITs. The latter were new SITs created after either a match within this study, as in the case of SIT2538, comprising 2 MDR isolates, or a match with another orphan strain recorded in SpolDB4 (SIT3093 matched a strain from Italy, whereas SIT3094 matched a strain from previous studies in Poland). Regarding clustering, a total of 26 (56.5%) clinical isolates were clustered (7 clusters containing 2 to 6 isolates per cluster), and 20 (43.5%) isolates were unique within this study (including the 4 orphan strains).
The clade assignment demonstrated that the highest number of MDR strains belonged to the ill-defined T family (13 strains, or 28.3% of all strains). The most prevalent shared spoligotype within this family was SIT53, representing the T1 sublineage (6 strains, or 13% of all strains and 46% of the T-clade strains). The second-largest group, comprising 8 (17.4%) of the analyzed strains, displayed spoligotypes related to those of the Haarlem family, most of them being representative of the H1 sublineage (SIT47, SIT1557, and SIT2333). The third-largest group comprised members of the LAM family (6 strains, or 13% of all the strains). All these strains displayed spoligotypes that belonged to the LAM9 subclade (SIT42 and SIT891). Four (8.7%) of the MDR isolates harbored the spoligotyping pattern (SIT1) characteristic of the Beijing family of strains. Two minor clades, namely, X and S, were represented by one and two isolates, respectively. An important proportion of the strains (12 strains, or 26.1% of all the strains) could not be assigned to any of the major clades described within the spoligotype database. A comparison with INH-monoresistant strains (n ϭ 71) ( Table 2) showed a lower clustering rate (but not significantly lower; 56.5% versus 70.4%) (Table 3) for the MDR strains, considered a proxy for recent transmission. The results also underlined a higher genotypic diversity (58.7% versus 42.2%) and a higher number of unique profiles (43.5% versus 29.6%) of the MDR isolates compared to the INHmonoresistant isolates (4) .
Although spoligotyping per se is not an appropriate method for assessing the burden of recently transmitted TB (it may overestimate the proportion of clustered cases [22] [23] [24] ), it serves as an efficient preliminary procedure in determining the genetic relatedness of M. tuberculosis isolates (8, 9, 15, 26, 30, 31, 34) . Furthermore, the interpretation of the clustering results in the context of recent transmission is fraught with several ambiguities. This is because the amount of transmission represented by molecular clustering depends on a number of methodological factors, such as the methodology employed, as mentioned above; sample size; or study duration. For the last All 27 patterns observed are shown, among which 4 were orphans, 20 belonged to SITs described in the database, and 3 were newly created. Information on genotypic lineages and distributions in neighboring countries, whenever available in the database, is also shown.
b
Clades were assigned following SpolDB4 rules; Unk, unknown patterns within any of the major clades described in SITVIT2. a All 27 patterns observed are shown, among which 5 were orphans, 20 belonged to SITs described in the database, and 5 were newly created. Information on genotypic lineages and distributions in neighboring countries, whenever available in the database, is also shown. b Clades were assigned following SpolDB4 rules; Unk, unknown patterns within any of the major clades described in SITVIT2. c Percentage of strains in the SITVIT2 database after incorporation of the spoligotypes from the present study (n ϭ 71). d Distribution in neighboring countries with data available in the SITVIT2 database on 5 November 2008. Three-letter country codes are as follows: DEU, Germany (n ϭ 704); CZE, Czech Republic (n ϭ 530); SWE, Sweden (n ϭ 379); POL, Poland (n ϭ 317; strains from previous studies); RUS, Kaliningrad, Russia (n ϭ 90). e New SITs created after a match within this study (SIT 2538; note that 2 INH-resistant strains matched 2 MDR strains within the same study period not included in the table) or with another orphan strain in SITVIT2 (SIT2504 matched a strain from Austria, SIT2567 and SIT3092 matched strains from previous studies in Poland, and SIT3091 matched a strain from Taiwan).
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on October 24, 2017 by guest http://jcm.asm.org/ two, the larger the number of TB cases included in the study, the higher the proportion of clustered or recently transmitted cases. Likewise, the observation time is positively associated with clustering, and it is considered that studies based on less than 2 years of sampling underestimate recent transmission (20, 35) . Given the small pool of analyzed strains and fact that the study period lasted only 1 year, the rate of clustering for MDR-TB and INH-monoresistant isolates (56.5% and 70.4%, respectively; the difference was not statistically significant; P ϭ 0.1252) in our study seems to be high. Nevertheless, there are conflicting results in the literature on the relative transmissibility of drug-resistant and drug-sensitive M. tuberculosis strains. While some studies showed that drugresistant isolates were less likely to be associated with clustering (46, 48) , others identified drug resistance as a strong predictor of being in a cluster (1, 10) . In spite of a high degree of genetic diversity, an important part (41.3%), of the analyzed MDR strains belonged to one of the four clusters SIT53, SIT891, SIT1, and SIT1557. The compactness of the MDR M. tuberculosis population structure was also apparent at the phylogenetic level, as four major lineages, i.e., the T, Haarlem, LAM, and Beijing families, compristed more than 67% of the isolates studied (Table 1) . With 30% of the isolates in the SpolDB4 database (9), the T family contains poorly informative, ubiquitous spoligotypes with obscure genealogies. It is supposed, however, that most of the spoligotypes within the T clade represent relatively old genotypes prevalent in Europe (9) . The Haarlem family, of European origin, comprises nearly 1/4 of the M. tuberculosis population in Europe, although it also accounts for a similar proportion of strains in the Caribbean and Central America (9, 17) . In both these regions, the Haarlem family is believed to represent a remnant of the post-Columbian European colonization (17, 41) . The finding of the Haarlem strains in our MDR population assumes particular significance in light of previous studies demonstrating the ability of the Haarlem genotypes to cause outbreaks of MDR-TB, as reported in Argentina (37), the Czech Republic (30) , and Tunisia (34). The association between drug resistance and the Haarlem family has also been observed in other studies. Strains of this family predominated among MDR-TB cases in Tehran, Iran, and drug-resistant TB cases in Hungary; the rates of infection by the Haarlem genotype were 33.5% (15) and 66.2% (28), respectively. The LAM family, which was the third-largest genogroup found in this study, has a geographical distribution concentrated in Latin America and the Mediterranean region. Strains of the LAM family are hypothesized to be of European descent, and their high rate of occurrence in Latin American countries is supposed to be linked to the Portuguese and Spanish colonization of the New World in the 15th century (8) . It is noteworthy that the LAM family of strains in our study was represented exclusively by the LAM9 genotype, which is considered to be ancestral to the entire LAM lineage (9) . This finding may speak in favor of the historical presence of the LAM genotype strains in this part of Europe. Also, the fact that an important proportion of Polish MDR strains belonged to the LAM family may be somewhat related to the situation observed in Poland's eastern neighbor, Russia, where the LAM genotypes represent as much as 30 to 50% of the MDR strains (26, 33) .
Upon review of the literature, the three genotype families characterized above (Haarlem, LAM, and T) appeared to be dominant in many European countries. They represent as much as 60% of M. tuberculosis strains isolated in Italy (31), 70% of the strains from Sweden (10), and 80% of the strains from France and Portugal (6, 11) . Thus, the population structure revealed in our study is characteristic of a European country. Nonetheless, the finding in this study of four strains belonging to the Beijing genotype requires special attention. This is because strains of this genotype possess high epidemiological potential due to their enhanced transmissibility, particular propensity for developing drug resistance, and increased virulence. The Beijing genotype strains were initially found in China but have spread globally in recent years. The prevalence of the Beijing family is remarkably high on the Asian continent, and in many countries (China, South Korea, Hong Kong, and Thailand) it far exceeds 50% (21) . In other parts of the world, the proportion of TB attributable to the Beijing genotype is much more variable: low in parts of Africa (44) . In Estonia and Latvia, the Beijing strains were the cause of 87% and 58% of the MDR-TB cases, respectively (29, 45) . In our study, the proportion of MDR strains belonging to the Beijing family (9%) was similar to those reported in Spain (6%) (39) and Denmark (8%) (32) . At the same time, it was about half of those reported in the Netherlands (17%) (7) and Sweden (22%) (19) . In all these countries, most of the patients with Beijing isolates were immigrants from Asia and Eastern Europe. Of the four Beijing strains identified in our study, only one was obtained from a foreign-born (Mongolian) patient. It is noteworthy that the number of MDR-TB cases due to the Beijing genotype in Poland remained stable. In a previous study on the molecular epidemiology of drug-resistant M. tuberculosis strains in Poland in 2000, four MDR and three non-MDR isolates were found to belong to the Beijing genotype. Three of those isolates (2 MDR and 1 non-MDR) were obtained from patients born in countries where the genotype is prevalent (38) . All this suggests that even if foreign-born persons constitute the main reservoir for the Beijing family strains, these strains are being transmitted in Poland, although at a very low rate. Whether previously proposed variable hostpathogen compatibility in M. tuberculosis (18) could explain the propensity of specific mycobacterial lineages (such as the T or Haarlem clade) to spread within the Polish population to the detriment of the Beijing genotype remains purely speculative and open to discussion. When comparing the genetic structure of the MDR strains with that of INH-monoresistant strains, some important features were observed. First, a total of 9 shared types (SIT37, SIT40, SIT47, SIT50, SIT53, SIT253, SIT280, SIT775, and SIT2538) described for the MDR strains were also found among INH-monoresistant strains. These spoligotypes comprised 34.8% of the former and 60.6% of the latter. This percentage difference was due to the fact that, for INH-resistant TB, spoligotype SIT53 accounted for 33.8% of all the cases (4) . No such predominance of a single genotype was observed among MDR-TB cases. This finding might be indicative of a greater ability of drug-monoresistant M. tuberculosis strains to spread within the population compared with that of MDR strains. Second, 76.1% of the MDR isolates and 71.8% of the INH-resistant isolates yielded spoligotypes that had been reported in Poland previously (including SIT2538, shared by 2 MDR strains and 2 INH-resistant strains). This observation, together with the fact that nearly half of the spoligotypes identified among both MDR (48.1%) and INH-monoresistant (43.3%) M. tuberculosis isolates are present in Poland's neighboring countries, indicates that the vast majority of MDR-and INH-resistant-TB cases are due to infections with strains actively circulating in Poland and/or its neighbors. The fact that all but two patients (one Mongolian, with MDR-TB, and one Ukrainian, with INH-resistant TB) were Polish underlines the importance of in-country transmission. Third, the phylogenetic analysis revealed that the two most prevalent clades among MDR and INH-resistant M. tuberculosis strains were T and Haarlem, representing 46% and 80% of these groups, respectively. These results corroborate previous observations on the predominance of the T and Haarlem genotypes in the epidemiology of drug-resistant TB in Poland (5, 38) . Furthermore, the presence of the T and Haarlem genotype isolates in such high proportions is consistent with the general features of the European population of M. tuberculosis.
Although the distributions of the four major clades (T, Haarlem, LAM, and Beijing) were significantly different in the MDR and INH-monoresistant strains (P ϭ 0.0003), the most striking feature was the exclusive presence of Beijing and LAM lineages in the MDR group (8.7% and 13%, respectively). This suggests that, in addition to the possible emergence of MDR strains from a pool of INH-monoresistant strains of the T, H1, H3, and S lineages, a proportion of MDR-TB cases could also arise due to ongoing transmission of specific genotypes, such as LAM and Beijing. To better recognize the population genetic relationships between INH-monoresistant (n ϭ 71) and MDR (n ϭ 46) M. tuberculosis isolates, we drew and compared MSTs of these 2 data sets independently ( Fig. 2A and B , respectively), as well as a combined tree for all the isolates together (n ϭ 117) (Fig. 2C) . As mentioned earlier, the greatest contributor to INH-monoresistant strains of M. tuberculosis in Poland is the cluster made up of SIT53 strains belonging to the T1 sublineage (33.8% of all INH-monoresistant strains). The T1 strains, represented by its prototype, SIT53, constitute the central node of the MST shown in Fig. 2A . Nonetheless, there are known difficulties associated with attempts to draw epidemiological inferences from ill-defined T-family spoligotypes (representing evolutionarily recent TB strains), which corresponded to about 30% of all entries in the SpolDB4 database present in all continents (9) . Based on single spacer differences, they were initially stratified into 5 sublineages (T1 to T5), out of which 8 nested clades with robust spoligotyping signatures have been extracted so far (T-Tuscany, T1-Russia, T2-Uganda, T3-Ethiopia, T3-Osaka, T4-Central Europe, T5-Madrid, and T5-Russia). Consequently, further molecular characterization of the isolates designated "T" by default (17) is needed before phylogenetic inferences are drawn from the central node made up of spoligotype SIT53. In the MST shown in Fig. 2A , it is immediately followed by SIT50 (9.9%), SIT47 (7%), and SIT1253 (2.8%), which are successively placed on the MST within the well-defined H3, H1, and S subgroups. The spoligotyping results and clade definitions were also linked to the distribution of clinical isolates within PGG1 versus PGG2/3 (characterized by the lack of spacers 33 to 36). With the exception of a single orphan strain with an unknown signature (the 5th strain from the top in Table 2 ), isolates causing the bulk of INH monoresistance in Poland were made up of evolutionarily modern lineages of tubercle bacilli (T, Haarlem, and S). The T and Haarlem lineages/sublineages were duly represented by prototypes that characterized their description in the SpolDB4 database (9): T1 (SIT53), T1_RUS (SIT280), T3 (SIT37), T4 (SIT40), T5 (SIT44), H1 (SIT47), and H3 (SIT50).
The MST of the MDR strains involved five major branches (Fig. 2B) . The largest essentially contained genotypes from the ill-defined T family. The other four branches exclusively or predominantly included genotypes from the Haarlem (H1 and H3), LAM, Beijing, and S families (Fig. 2B ). The genotype SIT53 had a central position in this MST similar to that of the INH-monoresistant strains. However, as stressed above, further molecular characterization of SIT53 node strains is needed before phylogenetic inferences are drawn. Thus, a distinctive feature of the MDR population was the presence of the Beijing and LAM family strains and a significantly lower proportion of Haarlem family strains compared with the INH-monoresistant population. This observation suggests that, in addition to acquired resistance to RMP occurring within a pool of INHmonoresistant strains, a nonnegligible proportion of MDR-TB in Poland is due both to active transmission within the autochthonous population and to frequent contacts with neighboring countries. A second-line typing using MIRU-VNTRs and detailed contact tracing, in conjunction with characterization of specific katG alleles shared among INH-monoresistant and MDR strains (33, 38, 46) , might be helpful to answer this question. Interestingly, a combined tree for all the isolates together ( Fig. 2C ) (n ϭ 117 isolates) reproduced most of the phylogenetic characteristics mentioned above for the MDR group. For example, similar to the MDR tree, the branches leading to the (i) T1_RUS, (ii) H1, and (iii) H3 sublineages were perfectly maintained, with the same succession of intermediary spoligotypes (Fig. 2C) . The lack of insertion of INH-monoresistant strains within these well-defined branches, in conjunction with the exclusive presence of LAM and Beijing lineage strains within the MDR subset, underlines an active transmission of MDR strains belonging to the T, H1, T1-RUS2, and H3 lineages. On the other hand, strains belonging to the LAM and Beijing genotypic families are apparently transmitted independently of the prevailing INH-monoresistant pool. At the level of PGG classification, the only PGG1 strains included 4 Beijing strains in the MDR-TB sample. Added to the single PGG1 orphan strain in the INH-monoresistant group (see above), the total study sample (n ϭ 117 strains) contained only 5, or 4.3%, of the PGG1 (ancient-lineage) strains compared to a very high proportion of PGG2/3 modern-lineage strains (112, or 95.7%). In conjunction with the noted absence of the CAS and EAI lineages in our study, this observation undeniably shows that circulating M. tuberculosis strains causing the bulk of drug resistance in Poland are made up of evolutionarily modern tubercle bacilli of the T, Haarlem, and S genotypic lineages.
Finally, we compared some of the basic epidemiological characteristics of the MDR-TB and INH-monoresistant-TB patients (Table 3 ). In both these groups, male patients predominated. The male-to-female ratios among MDR-TB patients and INH-resistant-TB patients were 6.7:1 and 2.7:1, respectively. Patients with MDR-TB were only slightly older than those with INH-resistant TB (median age, 50.5 versus 48 years). All of the patients studied were Polish, except two who were of Mongolian (MDR-TB group) and Ukrainian (INHresistant-TB group) origin. There were no differences between MDR-TB cases and INH-resistant cases in terms of prevalence by region of residence. The prevalence of TB, regardless of the resistance phenotype, was highest in the western region of Poland, followed by the central and eastern regions. The proportion of patients who reported a history of TB was significantly higher among MDR-TB patients than among INH-resistant TB patients (84.8% versus 22.5%; P Ͻ 0.0001). Patients with MDR-TB were also more likely to have acid-fast bacillus (AFB) smear-positive sputa (P ϭ 0.0014). The epidemiological status of MDR-TB in Poland, as inferred from patient demographic and clinical features, fits generally into the epidemiological picture of this infection described for other European countries. In a systemic review based on studies from 12 countries, being male, being less than 65 years old, and having a history of previous TB treatment were among major risk factors for MDR-TB in Europe (16) . A reported history of anti-TB medication, which, according to the cited study, was the strongest determinant of MDR-TB, may suggest the acquired nature of drug resistance. A strong correlation between MDR-TB and sputum smear positivity in our study is also noteworthy. Such a correlation, very seldom encountered in similar investigations (25) , may reflect the fact that patients with MDR-TB often did not receive adequate treatment at the outset (until the drug susceptibility results were available), thus remaining infectious for prolonged periods. A separate paper in preparation, devoted to the treatment of TB patients, shows that most, if not all, MDR-TB patients in Poland belong to the poorest members of the society; often having associated physical or mental handicaps, they were also characterized with poorer follow-up and longer delays to diagnosis and treatment (results not shown). Interestingly, there were virtually no MDR-TB cases among foreign-born persons in our study. This is in contrast to what has been observed in Western European countries, where the association between MDR-TB and being foreign born is remarkably consistent. The near absence of immigrants among MDR-TB cases can be explained by the relatively small immigrant population living in Poland.
In conclusion, our study is the first to provide a detailed population-based phylogenetic analysis of the MDR M. tuberculosis isolates compared to prevailing INH-monoresistant strains in Poland. Although spoligotyping, with its limited discriminatory power, may have overlooked finer intraspecies re- Some of the spoligotype-defined lineages and sublineages of the MDR group were shared by the INHmonoresistant group, which indicates that further contact-tracing epidemiology and a more discriminatory molecular methodology are warranted to pinpoint the major contributor to the development and persistence of MDR-TB in Poland. This is important in the context of the known instances of conversion reported in the literature from INH monoresistance to MDR (12) , in which 10 out of 12 INH-monoresistant strains converted to MDR after treatment failure during therapy. If confirmed in extended studies, it will constitute a data-supported instance of INH monoresistance conversion to MDR status in Poland. Nonetheless, the exclusive presence of LAM and Beijing family strains within the MDR group suggests a particular role of these genotypes in the etiology of MDR-TB emergence in Poland.
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